COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

You are here

Submissions Open to COVID-19 Applications

The NCL is temporarily opening its Assay Cascade characterization program to nanotech concepts with a focus on COVID-19. Those interested in applying for a COVID-19 concept can complete the NCL White Paper application found on our website. Submissions deadlines will follow the same quarterly submissions for cancer concepts—March, June, September & December.

The next deadline for application to NCL’s Assay Cascade characterization program—for both cancer and COVID-19 applications—is March 1, 2021. 

Have questions about the application? Please reach out to us and one of our staff will guide you through the process.